Can-Fite BioPharma Statistics

Total Valuation

TLV:CANF has a market cap or net worth of ILS 54.50 million. The enterprise value is 26.16 million.

Market Cap	54.50M
Enterprise Value	26.16M

Important Dates

The next estimated earnings date is Wednesday, May 28, 2025.

Earnings Date	May 28, 2025
Ex-Dividend Date	n/a

Share Statistics

TLV:CANF has 3.89 billion shares outstanding. The number of shares has increased by 70.22% in one year.

Current Share Class	3.89B
Shares Outstanding	3.89B
Shares Change (YoY)	+70.22%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	5.37%
Float	3.89B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	22.20
PB Ratio	2.75
P/TBV Ratio	2.75
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.91
EV / Sales	10.65
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.94

Financial Position

The company has a current ratio of 4.38, with a Debt / Equity ratio of 0.02.

Current Ratio	4.38
Quick Ratio	3.84
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -134.94% and return on invested capital (ROIC) is -85.96%.

Return on Equity (ROE)	-134.94%
Return on Assets (ROA)	-53.18%
Return on Invested Capital (ROIC)	-85.96%
Return on Capital Employed (ROCE)	-115.03%
Revenue Per Employee	490,982
Profits Per Employee	-5.74M
Employee Count	5
Asset Turnover	0.07
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.85% in the last 52 weeks. The beta is 0.25, so TLV:CANF's price volatility has been lower than the market average.

Beta (5Y)	0.25
52-Week Price Change	-51.85%
50-Day Moving Average	1.78
200-Day Moving Average	2.25
Relative Strength Index (RSI)	29.12
Average Volume (20 Days)	16,386,272

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TLV:CANF had revenue of ILS 2.45 million and -28.70 million in losses. Loss per share was -0.01.

Revenue	2.45M
Gross Profit	2.45M
Operating Income	-29.61M
Pretax Income	-28.70M
Net Income	-28.70M
EBITDA	-29.59M
EBIT	-29.61M
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 28.73 million in cash and 378,799 in debt, giving a net cash position of 28.35 million or 0.01 per share.

Cash & Cash Equivalents	28.73M
Total Debt	378,799
Net Cash	28.35M
Net Cash Per Share	0.01
Equity (Book Value)	19.80M
Book Value Per Share	0.01
Working Capital	25.24M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -27.82 million and capital expenditures -18,212, giving a free cash flow of -27.83 million.

Operating Cash Flow	-27.82M
Capital Expenditures	-18,212
Free Cash Flow	-27.83M
FCF Per Share	-0.01

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-1,206.23%
Pretax Margin	-1,169.14%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TLV:CANF does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-70.22%
Shareholder Yield	-70.22%
Earnings Yield	-52.66%
FCF Yield	-51.07%

Stock Splits

The last stock split was on May 12, 2013. It was a reverse split with a ratio of 0.04.

Last Split Date	May 12, 2013
Split Type	Reverse
Split Ratio	0.04

Scores

TLV:CANF has an Altman Z-Score of -25.3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-25.3
Piotroski F-Score	n/a